Skip to contentM
Mesa Laboratories Inc
M
MLABMesa Laboratories Inc Q1 2023 · 10-Q
Revenue$50.45M$50.45M+44.5% vs Q1 2022 Net Income-$1.44M-$1.44MN/M vs Q1 2022 EPS Diluted-$0.27-$0.27N/M vs Q1 2022 Gross Profit$31,341,000+41.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mesa Laboratories Inc · CIK 724004 · Engraved from SEC EDGAR
Operating Cash Flow-$2,811,000N/M Free Cash Flowderived-$3,036,000N/M Margins · derivedGross margin62.1%−1.5 pt vs Q1 2022
Operating margin-9.1%−18.0 pt vs Q1 2022
Net margin-2.9%−8.6 pt vs Q1 2022
ended Jun 30, 2022 · filed Aug 4, 2022 · 35 d after period end